Evidence map›Paper›PMID 40717185›Full record

Observational studyEuropean journal of nuclear medicine and molecular imaging2026

[

Peipei Wang, Sun Yu, Xiaorui Chen, Xinyue Zheng, Junqing Mao, Hongli Jing, Hongming Zhuang, Fang Li, Xinhui Su

2 registry-linked trialsAbstract readComparative StudyMulticenter StudyObservational Study
PubMed Publisher
In one paragraph

Observational study in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05069220 early_phase1recruitingnot on this map

A Study of 18F-MFBG Imaging for the Tumor Burden Evaluation or Diagnostic Performance in Pheochromocytoma, Paraganglioma and Neuroblastoma.

TypeinterventionalSponsorPeking Union Medical College HospitalRan2021 to 2026Enrolled150ConditionsNeuroendocrine Tumor, Neuroblastoma, Pheochromocytoma, ParagangliomaArms18F-MFBG, 68Ga-Dotatate
NCT06852807 recruitingnot on this map

Prospective Clinical Study of 18F-mFBG PET Imaging in Neuroblastoma

TypeobservationalSponsorFirst Affiliated Hospital of Zhejiang UniversityRan2025 to 2029Enrolled200ConditionsNeuroblastomaArms18F-MFBG
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. hNET-targeted [Theranostics · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Peipei WangDepartment of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, Zhejiang Province, China.
Sun YuDepartment of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, Zhejiang Province, China.
Xiaorui ChenDepartment of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, Zhejiang Province, China.
Xinyue ZhengDepartment of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, Zhejiang Province, China.
Junqing MaoDepartment of Internal Medicine, The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China.
Hongli JingDepartment of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100010, China.
Hongming ZhuangDepartment of Radiology, Children's Hospital of Philadelphia University of Pennsylvania Perelman School of Medicine, 34th & Spruce Street, Philadelphia, PA, 19104, USA. zhuang@chop.edu.
Fang LiDepartment of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, 100010, China. lifang@pumch.cn.
Xinhui SuDepartment of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, Zhejiang Province, China. suxinhui@zju.edu.cn.ORCID 0000-0002-4782-3982

Funding

National High Level Hospital Clinical Research Funding 2022-PUMCH-B-071National High Level Hospital Clinical Research Funding 2022-PUMCH-C-003
6 · The paper itself

Abstract

purpose[

methodsSixteen patients (median age 5.0 years, IQR 3.3-5.8 years) with confirmed history of neuroblastoma underwent paired [

results[

conclusionIn this head-to-head comparison, [ CLINICAL

trial registrationClinicaltrials.gov: NCT05069220 (Registered: 25 September 2021, retrospectively registered); Institute Review Board of Peking Union Medical College Hospital: ZS-2514. CLINICALTRIALS: gov: NCT06852807 (Registered: 24 February 2025, retrospectively registered); Institute Review Board of The First Affiliated Hospital of Zhejiang University School of Medicine: [2025 C] IIT No.008.

Indexed as

NeuroblastomaPositron Emission Tomography Computed TomographyReceptors, SomatostatinChildChild, PreschoolFemaleHumansMaleProspective StudiesRadiopharmaceuticalsRadiopharmaceuticalsReceptors, Somatostatin[18F]AlF-NOTA-octreotide[18F]MFBG[68Ga]Ga-DOTATATENeuroblastomaPediatric oncologySSTR

Identifiers

PMID40717185

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.